Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Nomegestrol acetate/estradiol: in oral contraception.

Yang LP, Plosker GL.

Drugs. 2012 Oct 1;72(14):1917-28. doi: 10.2165/11208180-000000000-00000.

PMID:
22950535
2.

Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.

Westhoff C, Kaunitz AM, Korver T, Sommer W, Bahamondes L, Darney P, Verhoeven C.

Obstet Gynecol. 2012 May;119(5):989-99. doi: 10.1097/AOG.0b013e318250c3a0.

PMID:
22525910
3.

Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.

Mansour D, Verhoeven C, Sommer W, Weisberg E, Taneepanichskul S, Melis GB, Sundström-Poromaa I, Korver T.

Eur J Contracept Reprod Health Care. 2011 Dec;16(6):430-43. doi: 10.3109/13625187.2011.614029. Epub 2011 Oct 13.

4.

A new contraceptive pill containing 17β-estradiol and nomegestrol acetate.

Christin-Maitre S, Laroche E, Bricaire L.

Womens Health (Lond). 2013 Jan;9(1):13-23. doi: 10.2217/whe.12.70. Review.

PMID:
23241152
5.
6.
7.
8.

Effects on bone mineral density of a monophasic combined oral contraceptive containing nomegestrol acetate/17β-estradiol in comparison to levonorgestrel/ethinylestradiol.

Sørdal T, Grob P, Verhoeven C.

Acta Obstet Gynecol Scand. 2012 Nov;91(11):1279-85. doi: 10.1111/j.1600-0412.2012.01498.x. Epub 2012 Aug 21.

PMID:
22762147
9.

Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: a double-blind, randomised, dose-finding pilot study.

Chabbert-Buffet N, Chassard D, Ochsenbein E, Thomas JL, Christin-Maitre S.

Eur J Contracept Reprod Health Care. 2011 Apr;16(2):76-84. doi: 10.3109/13625187.2011.554923. Epub 2011 Feb 21.

PMID:
21332383
10.

Zoely: a new combined oral contraceptive.

[No authors listed]

Drug Ther Bull. 2014 Aug;52(8):90-3. doi: 10.1136/dtb.2014.8.0270. Epub 2014 Aug 7. Review.

PMID:
25104773
11.

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.

Huber J, Foidart JM, Wuttke W, Merki-Feld GS, The HS, Gerlinger C, Schellschmidt I, Heithecker R.

Eur J Contracept Reprod Health Care. 2000 Mar;5(1):25-34. Erratum in: Eur J Contracept Reprod Health Care 2001 Mar;6(1):63.

PMID:
10836660
12.

Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.

Bachmann G, Sulak PJ, Sampson-Landers C, Benda N, Marr J.

Contraception. 2004 Sep;70(3):191-8.

PMID:
15325887
13.

[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China].

Caiyan W, Wen D, Qinping L, Huan S, Ziyan H, Liangdan T, Zheng'ai X, Yufeng L, Shulan Z, Baihua D, Xiaoyan X, Mulan R, Xiaomao L, Youdi X, Zhisong M, Meiqing X, Hongyu W, Zirong H.

Zhonghua Fu Chan Ke Za Zhi. 2014 May;49(5):355-9. Chinese.

PMID:
25030732
14.

Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.

Borges LE, Andrade RP, Aldrighi JM, Guazelli C, Yazlle ME, Isaia CF, Petracco A, Peixoto FC, Camargos AF.

Contraception. 2006 Dec;74(6):446-50. Epub 2006 Oct 19.

PMID:
17157100
15.
17.

Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study.

Christin-Maitre S, Serfaty D, Chabbert-Buffet N, Ochsenbein E, Chassard D, Thomas JL.

Hum Reprod. 2011 Jun;26(6):1338-47. doi: 10.1093/humrep/der058. Epub 2011 Mar 18.

PMID:
21421664
18.

[Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate].

Pintiaux A, Gaspard U, Nisolle M.

Rev Med Liege. 2012 Mar;67(3):152-6. Review. French.

PMID:
22611833
19.

Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study.

Jensen JT, Garie SG, Trummer D, Elliesen J.

Contraception. 2012 Aug;86(2):110-8. doi: 10.1016/j.contraception.2011.12.009. Epub 2012 Jan 26.

PMID:
22281416
20.

Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive.

Keam SJ, Wagstaff AJ.

Treat Endocrinol. 2003;2(1):49-70. Review.

PMID:
15871554

Supplemental Content

Support Center